Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Serious Comorbidities in Chronic Conditions

Introduction to Comorbidities

  • Serious comorbidities are chronic conditions that significantly increase morbidity, mortality, and reduce quality of life when they co-occur with other diseases, according to the American Thoracic Society and the American College of Cardiology 1, 2

Cardiovascular Comorbidities

  • Hypertension is the most prevalent comorbidity across multiple chronic conditions, occurring in over 80% of patients with ischemic heart disease, heart failure, atrial fibrillation, and stroke, as reported by the American Heart Association 2
  • Ischemic heart disease/coronary artery disease is a particularly common comorbidity that contributes to worsening health status, increased dyspnea, and decreased survival, according to the European Respiratory Society 3
  • Atrial fibrillation is a significant comorbidity that can complicate management of other conditions and increase mortality risk, as stated by the American College of Cardiology and the American Heart Association 2, 4

Respiratory Comorbidities

  • Chronic Obstructive Pulmonary Disease (COPD) is a major comorbidity that significantly impacts cardiovascular disease outcomes and overall mortality, according to the American Thoracic Society 1
  • Asthma/COPD overlap syndrome requires validation but represents a distinct phenotype with potentially different treatment approaches, as reported by the European Respiratory Society 3, 5
  • Obstructive sleep apnea, when co-occurring with COPD (overlap syndrome), treatment with continuous positive airway pressure has been shown to decrease mortality, according to the European Respiratory Society 3
  • Pulmonary hypertension, particularly when out-of-proportion, represents a serious comorbidity, as stated by the European Respiratory Society 3

Metabolic Comorbidities

  • Diabetes mellitus is present in 15.6% of COPD patients and ranks as the third most common comorbidity in patients with ischemic heart disease, according to the American Diabetes Association and the American Heart Association 2
  • Hyperlipidemia is the second most prevalent comorbidity across cardiovascular conditions, occurring in over 60% of patients with heart disease, as reported by the American College of Cardiology 2
  • Obesity complicates management of other conditions and contributes to reduced functional capacity, according to the American Thoracic Society and the American Heart Association 1, 4

Other Serious Comorbidities

  • Chronic kidney disease ranks among the top 10 comorbidities across multiple cardiovascular conditions, present in 30-45% of patients with heart disease, as reported by the American Heart Association 2
  • Anemia is present in 38-51% of patients with cardiovascular disease, ranking as the 4th-5th most common comorbidity, according to the American College of Cardiology 2
  • Cognitive dysfunction/dementia, particularly Alzheimer's disease, which ranks 10th among comorbidities in heart failure patients and 9th in stroke patients, as stated by the American Heart Association 2

Impact of Multiple Comorbidities

  • The median number of comorbidities among individuals with COPD has been reported as nine in some analyses, according to the American Thoracic Society 1
  • Multiple comorbidities increase healthcare utilization, costs, and complexity of medication regimens, as reported by the American Thoracic Society and the American Heart Association 1, 4

Common Comorbidity Combinations

  • Hypertension and hyperlipidemia is the most prevalent dyad, occurring in 57.2% of Medicare beneficiaries with at least 2 chronic conditions, according to the American College of Cardiology 2
  • Hypertension, hyperlipidemia, and ischemic heart disease is the most prevalent triad, occurring in 35.8% of Medicare beneficiaries with at least 3 chronic conditions, as reported by the American Heart Association 2
  • Hypertension, hyperlipidemia, and diabetes mellitus is the second most prevalent triad, according to the American Diabetes Association and the American Heart Association 2